Literature DB >> 2538704

Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease.

M Goedert1, A Fine, D Dawbarn, G K Wilcock, M V Chao.   

Abstract

Nerve growth factor (NGF) receptor mRNA was found to be widely distributed throughout the human central nervous system, with the highest levels in the basal forebrain; this suggests that NGF may function as a retrograde trophic messenger for basal forebrain magnocellular cholinergic nerve cells. The degeneration of the latter constitutes one of the main features of Alzheimer's disease and it may be responsible for some of the cognitive impairment that characterizes the disease. No evidence was obtained for an insufficient synthesis of NGF receptor mRNA in the basal forebrain in Alzheimer's disease, where NGF receptor-like immunoreactivity was confined to neuronal cell bodies. NGF could thus be therapeutically beneficial. It could be expected to induce basal forebrain cholinergic cells to hypertrophy, synthesize more choline acetyltransferase and extend neurites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538704     DOI: 10.1016/0169-328x(89)90011-9

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  11 in total

1.  Demonstration and characterization of hippocampal cholinergic neurostimulating peptide (HCNP) processing enzyme activity in rat hippocampus.

Authors:  Y Otsuka; K Ojika
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

Review 2.  Gangliosides, NGF, brain aging and disease: a mini-review with personal reflections.

Authors:  A Claudio Cuello
Journal:  Neurochem Res       Date:  2012-04-08       Impact factor: 3.996

3.  Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression.

Authors:  M G Spillantini; L Aloe; E Alleva; R De Simone; M Goedert; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 4.  Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance.

Authors:  Noralyn Basco Mañucat-Tan; Khalil Saadipour; Yan-Jiang Wang; Larisa Bobrovskaya; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

5.  TrkA gene ablation in basal forebrain results in dysfunction of the cholinergic circuitry.

Authors:  Efrain Sanchez-Ortiz; Daishi Yui; Dongli Song; Yun Li; John L Rubenstein; Louis F Reichardt; Luis F Parada
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

6.  A cell line producing recombinant nerve growth factor evokes growth responses in intrinsic and grafted central cholinergic neurons.

Authors:  P Ernfors; T Ebendal; L Olson; P Mouton; I Strömberg; H Persson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Measurement of human nerve growth factor binding sites in brain and in peripheral tissues by a specific immunoprecipitation assay.

Authors:  P Ehrhard; F Gudat; U Otten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

8.  Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease.

Authors:  Mark H Tuszynski; Jennifer H Yang; David Barba; Hoi-Sang U; Roy A E Bakay; Mary M Pay; Eliezer Masliah; James M Conner; Peter Kobalka; Subhojit Roy; Alan H Nagahara
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

9.  Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism.

Authors:  C Missale; F Boroni; S Sigala; A Buriani; M Fabris; A Leon; R Dal Toso; P Spano
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  The neurotrophins and their role in Alzheimer's disease.

Authors:  Shelley J Allen; Judy J Watson; David Dawbarn
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.